Sharepoint Solutions

PRODUCTS

  • Nunc Cell Factory Systems
    Nunc Cell Factory Systems

    A proven solution for large-scale production of cells, vaccines, and cellular therapeutics, these systems have the same growth kinetics as laboratory-scale cell culture products. The ports of the system make it easy to customize and close, with custom tubing assemblies that facilitate venting, filling, and harvesting.

    • Certified Sterility Assurance Level of 10-6
    • Nunclon™ Delta surface treatment for consistent performance from layer to layer and lot to lot
    • Available in 1, 2, 4, 10 and 40-tray versions
    • Easy to customize and create a closed system with the use of custom tubing assemblies that facilitate venting, filling and harvesting
  • Used Alexanderwerk Roller Compactor, Model WP200VN
    Used Alexanderwerk Roller Compactor, Model WP200VN

    Used Alexanderwerk roller compactor, model WP200VN, stainless steel cosntruction, 200 mm diameter x 75 mm faced rolls, cored rolls, nominally rated up to 400 kg/hr, with twin screw feeder with agitated feed hopper, cantilevered rolls, with flake crusher, pre granulator and fines granulator, on board hydraulic unit, cabinet design, 480 volt, serial# 054-00116, built 2004.

  • HT Series 3 Evaporator
    HT Series 3 Evaporator

    Genevac HT series evaporators are the ideal solution for parallel evaporation bottlenecks in high throughput and production laboratories having high performance and high sample capacities.

  • Ethical & Regulatory Review
    Ethical & Regulatory Review

    For 50 years, WIRB-Copernicus Group has stood as the gold standard of ethical and regulatory human research oversight, with more years of IRB and IBC experience and more deep, trusted relationships with sponsors, CROs, institutions, and investigators.

  • Pharmaceutical Sterilization And Depyrogenation Equipment
    Pharmaceutical Sterilization And Depyrogenation Equipment

    The safe and reliable sterilization and depyrogenation of pre-cleaned containers is the most important pre-treatment step in the pharmaceutical process. The modular HQL 6000,7000 and 8000 tunnel series offer maximum process safety and reproducible treatment quality combined with high flexibility, cost effectiveness and efficiency.

WHITE PAPERS AND CASE STUDIES

  • Choosing The Right Solution: Improving the Clinical Trial Site Feasibility Process
    Choosing The Right Solution: Improving the Clinical Trial Site Feasibility Process

    What are the things that high-performing clinical research sites do that make sponsors return to them again and again?

  • Reducing Readmissions: How A Post-Discharge Phone Call Reduces Hospital Readmissions
    Reducing Readmissions: How A Post-Discharge Phone Call Reduces Hospital Readmissions

    Each year, approximately 16 percent of patients in United States hospitals are readmitted within 30 days of discharge. Readmissions and the additional treatments they entail are costly to both patients and insurers. Increasingly, they are costly to hospitals as well. A portion of readmissions are considered unavoidable, such as a planned readmission for chemotherapy, or an unexpected adverse event unrelated to the original diagnosis. However, many other readmissions are considered preventable through high quality clinical care and effective patient education and discharge procedures.

  • The Impact Of Rater Training On Clinical Outcomes Assessment Data
    The Impact Of Rater Training On Clinical Outcomes Assessment Data

    Review the need for rater training in clinical trials and review publications that report data on rater characteristics, training modalities and outcomes in terms of accuracy and reliability of clinical outcomes data. 

  • Capturing Fast-Moving Ferrofluids On The Nanoscale
    Capturing Fast-Moving Ferrofluids On The Nanoscale

    When you pass a magnet over the surface of ferrofluid, it begins to reach out with its gooey, spikey arms. A team of researchers at Juniata College is using a Phantom high-speed camera to study its unique, magnetic particles that have vast implications for future lab-on-a-chip devices. 

  • Streamline Change Control In Today’s Complex Life Sciences Organizations
    Streamline Change Control In Today’s Complex Life Sciences Organizations

    One area coming under increased regulatory scrutiny is change control: the ability to manage deviations to established policies and procedures in a way that is efficient, timely and compliant.

  • Large PMA Study Of CRC Diagnostic
    Large PMA Study Of CRC Diagnostic

    A study needed to enroll approximately 12,000 subjects and was also unique because it required subjects to self-collect samples at home. Read about the risk management and mitigation that Health Decisions utilized to keep the study on track.

  • Celgene Leverages ERT eCOA Data for FDA Approval
    Celgene Leverages ERT eCOA Data for FDA Approval

    A biopharmaceutical company wanted to determine whether patients treated with an oral inhibitor of phosphodieasterase-4 (PDE-4) would show improvement in signs and symptoms of PsA. They used ERT eCOA tablets to collect data about patient symptoms as observed by physicians through the ACR assessment which was used to assess efficacy. Results showed reduced monitoring time and costs, decreased time to database lock, and FDA approval.

  • Objectively Tracking Lesions In Dermatology Clinical Trials
    Objectively Tracking Lesions In Dermatology Clinical Trials

    There is an increasing need for objectivity in mapping and analyzing of lesions to create confidence in trial findings, reproducibility and translation to clinical practice for dermatology sponsors, regulators and clinicians. This paper examines evolving diagnostic practices coupled with advancing technology and their application to reduce subjectivity in dermatology clinical trials.

  • Reconditioned And Rehabbed Filters Succeed At Large Treatment Plant
    Reconditioned And Rehabbed Filters Succeed At Large Treatment Plant

    A large treatment plant includes several treatment processes that contribute to providing quality recycled water pursuant to the state of California Title 22 regulations. Major treatment processes include raw wastewater pumping, preliminary treatment, primary treatment, secondary treatment, tertiary treatment with Parkson DynaSand® filters, and disinfection.

  • Usage Analytics: Solibri Applies Immediate And Actionable Usage Insights To Build Higher-Value Construction Software
    Usage Analytics: Solibri Applies Immediate And Actionable Usage Insights To Build Higher-Value Construction Software

    Today, construction firms are faster to recognize the benefits of innovative technology, says Solibri Product Manager Juan Rodriguez. But the far-reaching nature of Solibri’s users – professionals in multiple disciplines, on every continent – has made it hard to get timely and complete customer feedback. Solibri wanted a much better understanding of how our typical users are engaging with the software through anonymous usage data. If they created a new feature, was it successful? Has it been adopted? Why, or why not?”

  • Phase 3 Bacterial Vaginosis Study
    Phase 3 Bacterial Vaginosis Study

    Ensuring that studies meet the business goals of sponsors and increase the range of treatment options available to patients and healthcare providers can be challenging when a trial must enroll subjects with a bothersome health condition and ask them to risk randomization to placebo. The project team in a study of an investigational treatment for bacterial vaginosis addressed such challenges and enabled the study to meet the sponsor’s goals.

  • Biosimilars: Regulatory Trends And Manufacturing Considerations
    Biosimilars: Regulatory Trends And Manufacturing Considerations

    Regulatory approval of a biosimilar requires comprehensive knowledge of both the process and the molecule while process development with the end goal in mind will help to achieve a robust manufacturing process.

NEWS